About SAIC Frederick

SAIC-Frederick, Inc. develops and applies advanced technologies to accelerate the delivery of new treatments to patients with cancer and AIDS.

The company is a wholly owned subsidiary of Science Applications International Corporation and operates exclusively under a single, long-term contract to the National Cancer Institute, part of the U.S. National Institutes of Health.

SAIC-Frederick's staff of scientific, technical, and support professionals conducts basic and applied research in cancer and AIDS, and maintains a full suite of advanced technologies in areas such as nanotechnology, genomics, and biomedical imaging.

The Company

• Operates the federal government's vaccine and pharmaceutical manufacturing facilities, one for NCI and the other for the National Institute of Allergy and Infectious Diseases
• Operates the high-performance Advanced Biomedical Computing Center
• Supports more than 300 clinical trials for patients in the United States and around the world
• Develops new standards for using nanotechnology in safe and effective treatments for cancer and other diseases

SAIC-Frederick manages a pilot program of 30 community hospitals in 22 states that is exploring the best way to bring the most advanced, research-driven cancer care to patients in small-town, rural, and inner-city communities where they live, and to involve more patients in cancer research.

The company is facilitating the NCI Advanced Technology Partnerships Initiative, a major effort to accelerate the translation of basic research findings into effective new treatments for patients with cancer and AIDS.

SAIC-Frederick also makes research and development technologies available — consistent with the NCI mission — to other government agencies through the Economy Act and to academic institutions and corporate entities through a fee-for-service program.

---

---

A Federally Funded Research and Development Center (FFRDC)

NCI-Frederick is one of 39 Federally Funded Research and Development Centers (FFRDC). These are government-owned, contractor-operated entities best known as the federal national laboratories, such as Brookhaven, Argonne, Sandia, Oak Ridge, Los Alamos, and others.

The FFRDC is a special business model defined under government regulations that require the contractor to be autonomous, or a separate operating unit of a parent company, and to operate in the public interest. It also permits special access to privileged government information and facilities, and it allows broad latitude in subcontracting.

Authorities granted to the FFRDC guarantee flexibility, efficiency, rapid response, and accountability. This enables the FFRDC to respond rapidly to new and emerging mission-critical initiatives of NCI and to manage public-private partnerships that accelerate the delivery of new treatments to cancer patients.